Skip to content

Lymph Node Spread In Tonsil Cancer

Exploration of First Echelon Sentinel Lymph Node Drainage Of Squamous Cell Carcinoma Of The Tonsil Particularly With Reference To The Lateral Retropharyngeal Lymph Node Of Rouviere

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019551
Enrollment
10
Registered
2019-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C099- Malignant neoplasm of tonsil, unspecified

Interventions

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients above 18 years of age 2.Histologically proven squamous cell carcinoma of tonsil 3.T1-T4 tumours 4.Patients giving consent for surgical modality of treatment

Exclusion criteria

Exclusion criteria: 1.Patients who are poor candidates for general anesthesia 2.Tumours with unresectable neck nodes , vessel encasement of either the primary or the neck node 3.No clinical or radiological evidence of metastatic lymphadenopathy. 4.Previous surgery or radiotherapy to head and neck

Design outcomes

Primary

MeasureTime frame
To identify the sentinel node in carcinoma tonsil by radionucleide injection followed by SPECT â??CT To identify sentinel node in carcinoma tonsil by intraoperative use of gamma probe To identify sentinel node in carcinoma tonsil by intraoperative peritumoural injection of 1% methylene blue. To confirm metastatic deposit by serial step sectioning in all lymph nodal groups and retropharyngeal nodes . To determine p-16 positivity status in all patients . Timepoint: Day 1 of inclusion of the patient in to the study

Secondary

MeasureTime frame
1. To determine incidence of retropharyngeal lymph node involvement 2. To determine factors predicting retropharyngeal lymph node involvementTimepoint: none

Countries

India

Contacts

Public ContactSmriti Panda

All India Institute of Medical Sciences, New Delhi

smriti.panda.87@gmail.com9717827306

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 24, 2026